ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1918

Defining Pain That Does Not Interfere with Activities Among Rheumatoid Arthritis (RA) Patients

Yvonne C. Lee1, Patricia Katz2,3, Amanda Quebe4, Luna Sun4, Himanshu Patel4, Carol L. Gaich4, Natalie Boytsov4 and Kaleb Michaud5,6, 1Northwestern University Feinberg School of Medicine, Chicago, IL, 2Forward/National Data Bank for Rheumatic Diseases, Wichita, KS, 3University of California San Francisco, San Francisco, CA, 4Eli Lilly and Company, Indianapolis, IN, 5Rheumatology, University of Nebraska Medical Center, Omaha, NE, 6FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: activities of daily living (ADL), Fatigue, pain, Rheumatoid arthritis (RA) and work

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: 4M103 ACR Abstract: Pain Mechanisms–Basic & Clinical Science (1917–1922)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: RA patients differ in the degree to which pain interferes with function. To improve function, an understanding of this diversity is needed. Our objectives were to: (1) understand the degree to which pain interfered with specific activities, (2) characterize the distribution of pain intensity that does not interfere with activities (ie, non-interfering pain), and (3) identify characteristics associated with non-interfering pain.

Methods: Data were derived from subjects with rheumatologist-confirmed RA in FORWARD—The National Databank for Rheumatic Diseases. Subjects completed 8 items from the PROMIS Pain Interference Item Bank that asked the degree to which pain interfered with activities (from “not at all” to “very much”). If subjects reported any pain interference, they were asked, “At what level would pain no longer interfere with this activity?” Responses were collected using a 0-10 numeric rating scale (NRS; 10 = severe pain). Internal consistency of non-interfering pain items was assessed using Cronbach’s alpha and item-total correlations to determine if an overall mean of non-interfering pain could be calculated. Multiple linear regression analyses examined associations between non-interfering pain and the following characteristics: age, sex, disease duration, BMI, Rheumatic Disease Comorbidity Index, disability (Health Assessment Questionnaire), pain intensity NRS, fatigue NRS, self-reported current depression, sleep problems NRS, and fibromyalgianess (Polysymptomatic Distress Scale).

Results: As of April 2018, 1048 RA patients had completed questionnaires. Pain interference was most common for daily activities (70.1%) and least common for ability to concentrate (46.7%) (Table). The mean level at which pain no longer interfered with activities ranged from 2.7 ± 2.2 for ability to fall/stay asleep to 3.1 ± 2.1 for daily activities. Internal consistency across items was high (Cronbach’s alpha = 0.97). Overall, the mean threshold for non-interfering pain was 2.9 ± 2.0. Independent predictors of non-interfering pain were greater pain severity (β = 0.21, p < 0.0001) and lower fatigue (β = -0.11, p = 0.04). Other characteristics tested were not statistically significant at alpha = 0.05.

Conclusion: The mean pain level that did not interfere with activities was 3 (on a 0-10 scale) and did not vary depending on activity type. This may suggest that RA patients consider non-interfering pain to be a concept similar across different situations. Factors that may contribute to high non-interfering pain levels include pain and fatigue. Future studies are needed to determine if these associations, particularly that between pain intensity and non-interfering pain, reflect an artifact in rating (eg, patients who rate pain highly may also rate non-interfering pain highly) or underlying pathways that can be targeted to decrease the functional impact of pain.

Table. The proportion of RA patients who experience pain interference and the pain level at which pain does not interfere with activities (N = 1048)

Activity1

PROMIS Pain Interference Questions

Pain Level That Would Not Interfere With Activity

% Experienced Pain Interference

Mean ± SD

Median (IQR)

Daily activities

70.1%

3.1 ± 2.1

3 (2,4)

Work around the house

69.2%

3.1 ± 2.1

3 (2,4)

Household chores

66.9%

3.0 ± 2.1

2 (2,4)

Ability to fall asleep/stay asleep

61.6%

2.7 ± 2.2

2 (1,4)

Ability to work

62.9%

2.9 ± 2.2

2 (1,4)

Enjoyment of life

57.8%

2.8 ± 2.3

2 (1,4)

Social activities

55.2%

3.1 ± 2.1

3 (2,4)

Ability to concentrate

46.7%

2.8 ± 2.1

2 (1,4)

Abbreviation: IQR, interquartile range.
1Total number who responded to each question was 1047 for daily activities, 1046 for work around the house and household chores, 1044 for social activities, 1041 for ability to concentrate, 1040 for enjoyment of life, 1039 for fall asleep/stay asleep, and 458 for ability to work; 575 subjects did not answer the latter question because they were retired or otherwise not working.


Disclosure: Y. C. Lee, Pfizer, Inc., 2,Eli Lilly and Co., 6; P. Katz, None; A. Quebe, Eli Lilly and Company, 1, 3; L. Sun, Eli Lilly and Company, 1, 3; H. Patel, Lilly, 3; C. L. Gaich, Eli Lilly and Company, 1, 3; N. Boytsov, Lilly, 3; K. Michaud, None.

To cite this abstract in AMA style:

Lee YC, Katz P, Quebe A, Sun L, Patel H, Gaich CL, Boytsov N, Michaud K. Defining Pain That Does Not Interfere with Activities Among Rheumatoid Arthritis (RA) Patients [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/defining-pain-that-does-not-interfere-with-activities-among-rheumatoid-arthritis-ra-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/defining-pain-that-does-not-interfere-with-activities-among-rheumatoid-arthritis-ra-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology